Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis

被引:4511
作者
El-Serag, Hashem B. [1 ]
Rudolph, Lenhard
机构
[1] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Ctr Qual Care & Utilizat Studies, Houston, TX USA
[4] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany
关键词
D O I
10.1053/j.gastro.2007.04.061
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. HCC has several interesting epidemiologic features including dynamic temporal trends; marked variations among geographic regions, racial and ethnic groups, and between men and women; and the presence of several well-documented environmental potentially preventable risk factors. Moreover, there is a growing understanding on the molecular mechanisms inducing hepatocarcinogenesis, which almost never occurs in healthy liver, but the cancer risk increases sharply in response to chronic liver injury at the cirrhosis stage. A detailed understanding of epidemiologic factors and molecular mechanisms associated with HCC ultimately could improve our current concepts for screening and treatment of this disease.
引用
收藏
页码:2557 / 2576
页数:20
相关论文
共 184 条
  • [1] Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease
    Abdelmalek, Manal F.
    Liu, Chen
    Shuster, Jonathan
    Nelson, David R.
    Asal, Nabih R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (09) : 1162 - 1169
  • [2] A 2-MB YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(A) GENE FAMILY TO THE INSULIN-LIKE GROWTH-FACTOR-2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME-6 (6Q26-Q27)
    ACQUATI, F
    MALGARETTI, N
    HAUPTSCHEIN, R
    RAO, P
    GAIDANO, G
    TARAMELLI, R
    [J]. GENOMICS, 1994, 22 (03) : 664 - 666
  • [3] Excess risk of primary liver cancer in patients with diabetes mellitus
    Adami, HO
    Chow, WH
    Nyren, O
    Berne, C
    Linet, MS
    Ekbom, A
    Wolk, A
    McLaughlin, JK
    Fraumeni, JF
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) : 1472 - 1477
  • [4] The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    Adams, LA
    Lymp, JF
    St Sauver, J
    Sanderson, SO
    Lindor, KD
    Feldstein, A
    Angulo, P
    [J]. GASTROENTEROLOGY, 2005, 129 (01) : 113 - 121
  • [5] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    Adinolfi, LE
    Gambardella, M
    Andreana, A
    Tripodi, MF
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 2001, 33 (06) : 1358 - 1364
  • [6] [Anonymous], 1998, Lancet, V351, P1535
  • [7] The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
    Armstrong, GL
    Alter, MJ
    McQuillan, GM
    Margolis, HS
    [J]. HEPATOLOGY, 2000, 31 (03) : 777 - 782
  • [8] Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
    Artandi, SE
    Chang, S
    Lee, SL
    Alson, S
    Gottlieb, GJ
    Chin, L
    DePinho, RA
    [J]. NATURE, 2000, 406 (6796) : 641 - 645
  • [9] Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas
    Azechi, H
    Nishida, N
    Fukuda, Y
    Nishimura, T
    Minata, M
    Katsuma, H
    Kuno, M
    Ito, T
    Komeda, T
    Kita, R
    Takahashi, R
    Nakao, K
    [J]. ONCOLOGY, 2001, 60 (04) : 346 - 354
  • [10] PROMOTION MECHANISM OF PHENOBARBITAL AND PARTIAL-HEPATECTOMY IN DENA HEPATOCARCINOGENESIS CELL-KINETICS EFFECT
    BARBASON, H
    RASSENFOSSE, C
    BETZ, EH
    [J]. BRITISH JOURNAL OF CANCER, 1983, 47 (04) : 517 - 525